Annual SG&A
$16.01 M
+$745.00 K+4.88%
31 December 2023
Summary:
Immunic annual selling, general & administrative expenses is currently $16.01 million, with the most recent change of +$745.00 thousand (+4.88%) on 31 December 2023. During the last 3 years, it has risen by +$5.67 million (+54.91%). IMUX annual SG&A is now at all-time high.IMUX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.36 M
-$135.00 K-3.01%
30 September 2024
Summary:
Immunic quarterly selling, general & administrative expenses is currently $4.36 million, with the most recent change of -$135.00 thousand (-3.01%) on 30 September 2024. Over the past year, it has increased by +$582.00 thousand (+15.42%). IMUX quarterly SG&A is now -51.48% below its all-time high of $8.98 million, reached on 30 June 2019.IMUX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.80 B
-$96.90 M-5.69%
30 September 2024
Summary:
Immunic TTM selling, general & administrative expenses is currently -$1.80 billion, with the most recent change of -$96.90 million (-5.69%) on 30 September 2024. Over the past year, it has dropped by -$1.81 billion (-11684.68%). IMUX TTM SG&A is now -2454.29% below its all-time high of $18.09 million, reached on 30 September 2024.IMUX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMUX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.9% | +15.4% | -10000.0% |
| 3 y3 years | +54.9% | +49.9% | -10000.0% |
| 5 y5 years | +17.8% | +109.9% | -10000.0% |
IMUX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +54.9% | -15.3% | +49.9% | -213.2% | at low |
| 5 y | 5 years | at high | +54.9% | -15.3% | +109.9% | -701.4% | at low |
| alltime | all time | at high | +422.1% | -51.5% | +291.0% | -2454.3% | at low |
Immunic Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.36 M(-3.0%) | $18.09 M(+3.3%) |
| June 2024 | - | $4.49 M(-12.7%) | $17.51 M(+3.8%) |
| Mar 2024 | - | $5.14 M(+25.6%) | $16.86 M(+5.4%) |
| Dec 2023 | $16.01 M(+4.9%) | $4.10 M(+8.6%) | $16.01 M(+3.1%) |
| Sept 2023 | - | $3.77 M(-1.9%) | $15.53 M(+1.3%) |
| June 2023 | - | $3.85 M(-10.2%) | $15.34 M(-1.4%) |
| Mar 2023 | - | $4.29 M(+18.4%) | $15.56 M(+2.0%) |
| Dec 2022 | $15.26 M(+14.8%) | $3.62 M(+1.2%) | $15.26 M(+1.9%) |
| Sept 2022 | - | $3.58 M(-12.1%) | $14.98 M(+4.7%) |
| June 2022 | - | $4.07 M(+2.1%) | $14.31 M(+4.7%) |
| Mar 2022 | - | $3.99 M(+19.4%) | $13.67 M(+2.8%) |
| Dec 2021 | $13.30 M(+28.7%) | $3.34 M(+15.0%) | $13.30 M(+2.5%) |
| Sept 2021 | - | $2.91 M(-15.3%) | $12.97 M(+3.2%) |
| June 2021 | - | $3.43 M(-5.1%) | $12.57 M(+10.5%) |
| Mar 2021 | - | $3.62 M(+20.0%) | $11.37 M(+10.0%) |
| Dec 2020 | $10.33 M(-28.8%) | $3.01 M(+20.3%) | $10.33 M(+9.0%) |
| Sept 2020 | - | $2.50 M(+12.1%) | $9.48 M(+4.8%) |
| June 2020 | - | $2.23 M(-13.4%) | $9.05 M(-42.7%) |
| Mar 2020 | - | $2.58 M(+19.4%) | $15.79 M(+8.8%) |
| Dec 2019 | $14.52 M(+6.9%) | $2.16 M(+4.1%) | $14.52 M(-2.5%) |
| Sept 2019 | - | $2.08 M(-76.9%) | $14.89 M(-15.7%) |
| June 2019 | - | $8.98 M(+586.9%) | $17.67 M(+36.5%) |
| Mar 2019 | - | $1.31 M(-48.4%) | $12.95 M(-18.9%) |
| Dec 2018 | $13.59 M | $2.53 M(-47.9%) | $15.98 M(-11.4%) |
| Sept 2018 | - | $4.86 M(+14.1%) | $18.04 M(+11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $4.26 M(-1.8%) | $16.13 M(+10.6%) |
| Mar 2018 | - | $4.33 M(-5.6%) | $14.59 M(+9.6%) |
| Dec 2017 | $13.31 M(+18.7%) | $4.59 M(+55.6%) | $13.31 M(+13.9%) |
| Sept 2017 | - | $2.95 M(+8.7%) | $11.69 M(+1.6%) |
| June 2017 | - | $2.71 M(-11.2%) | $11.51 M(+0.2%) |
| Mar 2017 | - | $3.06 M(+3.2%) | $11.48 M(+2.3%) |
| Dec 2016 | $11.22 M(-9.1%) | $2.96 M(+7.0%) | $11.22 M(-0.9%) |
| Sept 2016 | - | $2.77 M(+3.1%) | $11.32 M(+0.7%) |
| June 2016 | - | $2.69 M(-4.0%) | $11.24 M(-7.0%) |
| Mar 2016 | - | $2.80 M(-8.6%) | $12.08 M(-2.1%) |
| Dec 2015 | $12.35 M(+13.7%) | $3.06 M(+13.8%) | $12.35 M(-0.5%) |
| Sept 2015 | - | $2.69 M(-23.9%) | $12.41 M(+1.0%) |
| June 2015 | - | $3.53 M(+15.3%) | $12.29 M(+9.1%) |
| Mar 2015 | - | $3.06 M(-2.0%) | $11.27 M(+3.7%) |
| Dec 2014 | $10.86 M(+13.0%) | $3.13 M(+21.9%) | $10.86 M(+5.2%) |
| Sept 2014 | - | $2.57 M(+2.1%) | $10.33 M(-4.0%) |
| June 2014 | - | $2.51 M(-5.4%) | $10.77 M(-0.1%) |
| Mar 2014 | - | $2.66 M(+2.4%) | $10.78 M(+12.1%) |
| Dec 2013 | $9.62 M(+114.5%) | $2.59 M(-13.6%) | $9.62 M(+18.2%) |
| Sept 2013 | - | $3.00 M(+18.9%) | $8.13 M(+30.0%) |
| June 2013 | - | $2.52 M(+69.0%) | $6.26 M(+67.7%) |
| Mar 2013 | - | $1.49 M(+34.1%) | $3.73 M(+66.8%) |
| Dec 2012 | $4.48 M(+46.2%) | $1.11 M(-0.8%) | $2.24 M(+99.2%) |
| Sept 2012 | - | $1.12 M | $1.12 M |
| Dec 2011 | $3.07 M | - | - |
FAQ
- What is Immunic annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Immunic?
- What is Immunic annual SG&A year-on-year change?
- What is Immunic quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Immunic?
- What is Immunic quarterly SG&A year-on-year change?
- What is Immunic TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Immunic?
- What is Immunic TTM SG&A year-on-year change?
What is Immunic annual selling, general & administrative expenses?
The current annual SG&A of IMUX is $16.01 M
What is the all time high annual SG&A for Immunic?
Immunic all-time high annual selling, general & administrative expenses is $16.01 M
What is Immunic annual SG&A year-on-year change?
Over the past year, IMUX annual selling, general & administrative expenses has changed by +$745.00 K (+4.88%)
What is Immunic quarterly selling, general & administrative expenses?
The current quarterly SG&A of IMUX is $4.36 M
What is the all time high quarterly SG&A for Immunic?
Immunic all-time high quarterly selling, general & administrative expenses is $8.98 M
What is Immunic quarterly SG&A year-on-year change?
Over the past year, IMUX quarterly selling, general & administrative expenses has changed by +$582.00 K (+15.42%)
What is Immunic TTM selling, general & administrative expenses?
The current TTM SG&A of IMUX is -$1.80 B
What is the all time high TTM SG&A for Immunic?
Immunic all-time high TTM selling, general & administrative expenses is $18.09 M
What is Immunic TTM SG&A year-on-year change?
Over the past year, IMUX TTM selling, general & administrative expenses has changed by -$1.81 B (-11684.68%)